Longevity extension of worker honey bees (Apis mellifera) by royal jelly: optimal dose and active ingredient

per Yang, Wenchao, Tian, Yuanyuan, Han, Mingfeng, Miao, Xiaoqing
Publicat a PeerJ (2017)

Anti-hypertensive and cardioprotective effects of a novel apitherapy formulation via upregulation of peroxisome proliferator-activated receptor-α and -γ in spontaneous hypertensive...

per Sun, Yanru, Han, Mingfeng, Shen, Zhenhuang, Huang, Haibo, Miao, Xiaoqing
Publicat a Saudi J Biol Sci (2018)

A Study on the Predictors of Disease Severity of COVID-19

per Li, Liang, Sun, Wei, Han, Mingfeng, Ying, Yunli, Wang, Quanzhi
Publicat a Med Sci Monit (2020)

Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19

per Zha, Lei, Shen, Ya, Pan, Lingling, Han, Mingfeng, Yang, Gang, Teng, Xiaobao, Tefsen, Boris
Publicat a J Infect (2021)

Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67

per Cui, Minhu, Jin, Mingji, Han, Mingfeng, Zang, Yingda, Li, Chuangjun, Zhang, Dongming, Huang, Wei, Gao, Zhonggao, Yin, Xuezhe
Publicat a Int J Nanomedicine (2020)

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19

per Gao, Yong, Li, Tuantuan, Han, Mingfeng, Li, Xiuyong, Wu, Dong, Xu, Yuanhong, Zhu, Yulin, Liu, Yan, Wang, Xiaowu, Wang, Linding
Publicat a J Med Virol (2020)

COVID-19 induced liver function abnormality associates with age

per Li, Shasha, Li, Jinsong, Zhang, Zhenhua, Tan, Lin, Shao, Tuo, Li, Ming, Li, Xiuyong, Holmes, Jacinta A., Lin, Wenyu, Han, Mingfeng
Publicat a Aging (Albany NY) (2020)

Improving anti-tumor outcomes for colorectal cancer therapy through in situ thermosensitive gel loading harmine

per Li, Zhenzhen, Chen, Liqing, He, Chenghui, Han, Ying, Han, Mingfeng, Zhang, Yingying, Qi, Lingling, Xing, Xuezhong, Huang, Wei, Gao, Zhonggao, Xing, Jianguo
Publicat a Am J Transl Res (2020)

Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China

per Wang, Ruirui, Pan, Min, Zhang, Xiumei, Han, Mingfeng, Fan, Xiaoyun, Zhao, Fengde, Miao, Manli, Xu, Jing, Guan, Minglong, Deng, Xia, Chen, Xu, Shen, Leilei
Publicat a Int J Infect Dis (2020)

Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study

per Zheng, Xueying, Luo, Sihui, Sun, Yong, Han, Mingfeng, Liu, Jian, Sun, Liangye, Zhang, Liangming, Ling, Ping, Ding, Yu, Jin, Tengchuan, Liu, Zhirong, Weng, Jianping
Publicat a Natl Sci Rev (2020)

Effective treatment of severe COVID-19 patients with tocilizumab

per Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
Publicat a Proc Natl Acad Sci U S A (2020)

Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference

per Zhang, Yafei, Wang, Changtai, Han, Mingfeng, Ye, Jun, Gao, Yong, Liu, Zhongping, He, Tengfei, Li, Tuantuan, Xu, Mengyuan, Zhou, Luping, Zou, Guizhou, Lu, Mengji, Zhang, Zhenhua
Publicat a Virol Sin (2020)

Correction to: Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference

per Zhang, Yafei, Wang, Changtai, Han, Mingfeng, Ye, Jun, Gao, Yong, Liu, Zhongping, He, Tengfei, Li, Tuantuan, Xu, Mengyuan, Zhou, Luping, Zou, Guizhou, Lu, Mengji, Zhang, Zhenhua
Publicat a Virol Sin (2020)

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention

per Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
Publicat a Proc Natl Acad Sci U S A (2020)

Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients

per Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
Publicat a Proc Natl Acad Sci U S A (2020)

Differentially expressed immune response genes in COVID-19 patients based on disease severity

per Li, Shasha, Duan, Xiaoqiong, Li, Yujia, Li, Ming, Gao, Yong, Li, Tuantuan, Li, Shilin, Tan, Lin, Shao, Tuo, Jeyarajan, Andre J., Chen, Limin, Han, Mingfeng, Lin, Wenyu, Li, Xiuyong
Publicat a Aging (Albany NY) (2021)

Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial

per Hu, Ke, Guan, Wei-jie, Bi, Ying, Zhang, Wei, Li, Lanjuan, Zhang, Boli, Liu, Qingquan, Song, Yuanlin, Li, Xingwang, Duan, Zhongping, Zheng, Qingshan, Yang, Zifeng, Liang, Jingyi, Han, Mingfeng, Ruan, Lianguo, Wu, Chaomin, Zhang, Yunting, Jia, Zhen-hua, Zhong, Nan-shan
Publicat a Phytomedicine (2021)

Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity

per Han, Mingfeng, Xu, Mengyuan, Zhang, Yafei, Liu, Zhongping, Li, Shasha, He, Tengfei, Li, Jinsong, Gao, Yong, Liu, Wanjun, Li, Tuantuan, Chen, Zixiang, Huang, Xin, Cheng, Guoling, Wang, Jun, Dittmer, Ulf, Witzke, Oliver, Zou, Guizhou, Li, Xiuyong, Lu, Mengji, Zhang, Zhenhua
Publicat a Med Microbiol Immunol (2020)

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

per Tang, Wei, Cao, Zhujun, Han, Mingfeng, Wang, Zhengyan, Chen, Junwen, Sun, Wenjin, Wu, Yaojie, Xiao, Wei, Liu, Shengyong, Chen, Erzhen, Chen, Wei, Wang, Xiongbiao, Yang, Jiuyong, Lin, Jun, Zhao, Qingxia, Yan, Youqin, Xie, Zhibin, Li, Dan, Yang, Yaofeng, Liu, Leshan, Qu, Jieming, Ning, Guang, Shi, Guochao, Xie, Qing
Publicat a BMJ (2020)

Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial

per Wang, Dongsheng, Fu, Binqing, Peng, Zhen, Yang, Dongliang, Han, Mingfeng, Li, Min, Yang, Yun, Yang, Tianjun, Sun, Liangye, Li, Wei, Shi, Wei, Yao, Xin, Ma, Yan, Xu, Fei, Wang, Xiaojing, Chen, Jun, Xia, Daqing, Sun, Yubei, Dong, Lin, Wang, Jumei, Zhu, Xiaoyu, Zhang, Min, Zhou, Yonggang, Pan, Aijun, Hu, Xiaowen, Mei, Xiaodong, Wei, Haiming, Xu, Xiaoling
Publicat a Front Med (2021)